Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects

Clinica Chimica Acta

Volumn 398, Issue 1-2, 2008, Pages 99-104

  Moon, Hyun Duk ^a   Nakajima, Katsuyuki ^a   Kamiyama, Kiyoshi ^b   Takanashi, Kunihiko ^b   Sakurabayashi, Ikunosuke ^c   Nagamine, Takeaki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Department of Clinical Laboratory   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Angiopoietin like protein 3; Cholesteryl ester transfer protein; HDL cholesterol; Hyperalphalipoproteinemia

Indexed keywords

ADIPONECTIN; ANGIOPOIETIN LIKE PROTEIN 3; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; PROBUCOL; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERALPHALIPOPROTEINEMIA; HYPERLIPIDEMIA; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHENOTYPE; PRIORITY JOURNAL; SERUM;

ADIPONECTIN; ADOLESCENT; AGED; ANGIOPOIETINS; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; JAPAN; MALE; MIDDLE AGED; PHENOTYPE; REFERENCE VALUES; TRIGLYCERIDES; YOUNG ADULT;

EID: 54049101444     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.08.021     Document Type: Article

References (32)

1. Ge H., Cha J.Y., Gopal H., et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 46 (2005) 1484-1489
2. Koishi R., Ando Y., Ono M., et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 30 (2002 Feb) 151-157
3. Shimizugawa T., Ono M., Shimamura M., et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277 (2002) 33742-33748
4. Shimamura M., Matsuda M., Yasumo H., et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27 (2007) 366-372
5. Jin W., Wang X., Millar J.S., et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6 (2007) 129-136
6. Inazu A., Koizumi J., Kajinami K., Kiyohar T., Chichibu K., and Mabuchi H. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma. Atherosclerosis 145 (1999) 405-413
7. Noto H., Kawamura M., Hashimoto Y., et al. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Atherosclerosis 171 (2003) 131-136
8. Okamoto H., Yonemori F., Wakitani K., Minowa T., Maeda K., and Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 406 (2000) 203-207
9. de Grooth G.J., Kuivenhoven J.A., Stalenhoef A.F., et al. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 105 (2002) 2159-2165
10. Schaefer E.J., and Asztalos B.F. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am J Cardiol 100 (2007) 25-31
11. Nissen S.E., Tardif J.C., Nicholls S.J., et al. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356 (2007) 1304-1316
12. Sirtori C.R., and Mombelli G. Viability of developing CETP inhibitors. Cardiovasc Ther 26 (2008) 135-146
13. Kamiyama K., Fukuchi S., Tanaka K., et al. Serum glucose and lipid levels of Urawa inhabitants at health checkup. Saitama Med J 35 (2000) 434-440 (in Japanese)
14. Nakajima K., Daimon M., Kamiyama K., et al. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia. Ann Clin Biochem 44 (2007) 353-359
15. McCoy M.G., Sun G.S., Marchadier D., Maugeais C., Glick J.M., and Rader D.J. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 43 (2002) 921-929
16. Gómez Rosso L, Meroño T, Benítez MB, et al. Low adiponectin levels in primary hypertriglyceridemic male patients. Nutr Metab Cardivasc in press [May 8, Electronic publication ahead of print].
17. Vergès B., Petit J.M., Duvillard L., et al. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 26 (2006) 1364-1369
18. Miida T, Seino U, Miyazaki O, et al. Probucol markedly reduces HDL phospholipids and increased prebeta1-HDL without delayed conversion into alpha-migrating HDL: Putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis in press [Feb 13, Electronic publication ahead of print].
19. Nishimura A., and Sawai T. Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clin Chim Acta 371 (2006) 163-168
20. Eto M., Watanabe K., and Makino I. Increased frequencies of apolipoporotein E2 and E4 alleles in patients with ischemic heart disease. Clin Genet 36 (1989) 183-188
21. Hatsuda S., Shoji T., Shinohara K., et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subject. J Vasc Res 44 (2007) 61-66
22. Stejskal D., Karpisek M., Humenanska V., Solichova P., and Stejskal P. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA. Gen Physiol Biophys 26 (2007) 230-233
23. Inazu A., Koizumi J., and Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 11 (2000) 389-396
24. Jeppesen J. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen male study. Metab Syndr Relat Disord 1 (2003) 33-53
25. Akita H., Chiba H., Tsuchihashi K., et al. Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high-density lipoprotein cholesterol content. J Clin Endocrinol Metab 79 (1994) 1615-1618
26. Nagano M., Yamashita S., Hirano K., et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 11 (2004) 110-121
27. Badellino K.O., Wolfe M.L., Reilly M.P., and Rader D.J. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3 (2006) 22
28. Imamura S., Kobayashi J., Nakajima K., et al. A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma. J Lipid Res 49 (2008) 1431-1437
29. Okazaki M., Usui S., Nakamura3 M., and Yamashita S. Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification. Clin Chim Acta 395 (2008) 62-67
30. Ikewaki K., Mabuchi H., Teramoto T., et al. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects. Metabolism 52 (2003) 1564-1570
31. Ishida T., Choi S., Kundu R.K., et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 111 (2003) 347-355
32. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 223 (1993) 53-71